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Abstract
Background: Normothermic and hypothermic oxygenated perfusion for donation after circulatory death in kidney
transplantation are becoming popular in Italy, with the purpose of reducing the risk of primary non function and
delayed graft function due to the prolonged warm ischemia time.
Potential complications related to these procedures are currently under investigation and are continuously
emerging with the increasing experience. Post-operative infections - in particular graft arteritis - are a rare
complication but determine high risk of mortality and of graft loss.
The acute onset of the arterial complications makes it very difficult to find an effective treatment, and early
diagnosis is crucial for saving both patient and graft. Prevention of such infections in this particular setting are
advisable.
Case presentation: We present a patient with an acute arterial rupture after transplantation of a DCD graft treated
in-vivo hypothermic oxygenated perfusion. The cause was a severe arteritis of the renal artery caused by Candida
krusei and Pseudomonas aeruginosa. We discussed our treatment and we compared it to the other reported series.
Conclusion: Fungal infections in DCD transplant may be treacherous and strategies to prevent them should be
advocated.
Keywords: Transplant, Infections, Arteritis, Candida krusei, Pseudomonas aeruginosa
Background
Post-transplant infections represent a major cause of mor-
bidity and mortality. Pathogens may origin from either the
donor or the recipient, and often show a predictable time-
line of onset [1]. In the first post-transplant month gram-
negative bacteria and fungi can determine a fatal outcome,
especially in the case of invasive candidiasis, also because
of its potentially insidious presentation [2].
Although data are not univocal, a higher infection rate
has been reported in recipients of kidney transplants
from donors after circulatory death (DCD) compared to
donors after brain death (DBD) [3–5].
In this manuscript we report an acute arterial rupture
of a DCD graft due to severe arteritis of the renal artery
caused by Candida krusei and Pseudomonas aeruginosa.
Case presentation
A 57-years-old patient received a DCD kidney after 2
years of peritoneal dialysis. The donor was a 60-years-
old man, DCD Maastricht class III, died for cardiac
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arrest with an anamnesis of arterial hypertension. The
donor was hospitalized for 7 days, 15 h and 19 min be-
fore explantation. Central venous catheter (CVC) blood
cultures were positive for E. coli extended spectrum
beta-lactamase (ESBL) producing, while blood cultures
from peripheral vein were negative. Urine culture was
negative and bronchoalveolar lavage (BAL) was positive
for E. coli. No antibiotic therapy was performed. After
three hours of extracorporeal membrane oxygenation
(ECMO), the graft was treated ex-vivo with hypothermic
oxygenated machine perfusion for 90 min, as of our cen-
ter practice [6]. Pre-implantation biopsy reported a total
Karpinsky score of 2 (interstitial fibrosis: 1, vascular dis-
ease: 1). The patient and the donor shared 3 human
leukocyte antigens, one from class I and two from class
II. A cefazolin-based perioperative therapy was started,
and the graft was implanted in the right iliac fossa; upon
reperfusion the graft showed immediately a good perfu-
sion after eight hours of cold ischemia, and the periton-
eal catheter was removed. Immunosuppressive therapy
consisted in Basiliximab, steroids, tacrolimus, and myco-
phenolic acid. The immediate post-operative period was
characterized by delayed graft function (DGF), requiring
hemodialysis until post-transplant day 10. Four days
after transplant, donor’s blood cultures resulted positive
for a multi-susceptible Escherichia coli; moreover our
patient developed a superficial infection of the surgical
wound sustained by Pseudomonas aeruginosa, with per-
sistently negative surveillance blood cultures.
The patient subsequently developed chill and fever
with acute rise in C-reactive protein (CRP) and procalci-
tonin (PCT). Given the presence of sepsis, P. aeruginosa
wound infection and E. coli ESBL-producing positive
blood cultures from the donor, antibacterial therapy with
meropenem – according to the donor’s antibiogram –
was undertaken 8 days after kidney transplant. The ini-
tial dosage was 250 mg every 8 h and 1 g as extra-dose
after each hemodialysis session.
The day before discharge the patient complained an
acute abdominal pain; a computed tomography (CT)
showed no remarkable findings, but a small collection in
the right iliac fossa (Fig. 1a). White blood cells count
and renal function were stable compared to the day be-
fore, and after a couple of hours the pain spontaneously
improved; therefore no other procedures were planned.
Seven hours later the pain acutely started again, and a
second CT scan showed absence of blood flow in the ar-
tery of the graft, due to its complete rupture (Fig. 1b).
Meropenem therapy was still ongoing in this phase. The
patient was immediately brought to the operatory room,
where a complete rupture of the renal artery was found
between the anastomosis and the hilum, with massive
hemorrhage. The graft was removed, and the iliac ar-
tery was subsequently clamped and repaired using a
crio-preserved graft, with complete removal of the graft’s
artery. Samples were collected and sent for histological
and microbiological evaluation.
Upon suspicion of invasive fungal infection, anidula-
fungin therapy was started immediately after transplan-
tectomy with a dosage of 100 mg every 24 h. Serum
beta-D-glucan on blood samples collected after reinter-
vention was 523.4 pg/ml.
Fig. 1 TC scan at different time: a at the time of patient pain, b few
hours after the first CT scan and c revision of the imagining by an
expert radiologist
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Microbiological analyses on the artery wall resulted
positive for Pseudomonas aeruginosa and Candida kru-
sei, while cultures from the ureteral stent resulted posi-
tive for Candida krusei.
Pseudomonas aeruginosa isolated from the wound was
similar to that isolated from the aneurysm: the antibio-
gram showed sensitivity to meropenem (MIC ≤0.25), pi-
peracillin/tazobactam (MIC ≤2), gentamycin (MIC 2),
ciprofloxacin (MIC 0.5), ceftazidime (MIC 2), cefepime
(MIC 8) and amikacin (MIC 4).
The histology report concluded for a severe arteritis: an
intense inflammatory reaction was present in both intima
and avventitia, with a wide transmural necrotic area. The
artery wall showed chronic and acute inflammation with
focal necrosis and moderate arteriosclerosis with fibrosis
and calcification, without documented hyphae.
Multiple antimicrobial therapy based on anidulafungin
and meropenem was subsequently carried on for about
1 month. After reintervention the patient developed
positive CVC blood cultures by E. faecalis and S. epider-
midis, that did not require any further antimicrobial
therapy implement.
Meropenem was continued until day 18 after transplan-
tectomy with a fast improvement of cutaneous signs,
white blood cells count, and serum CRP and PCT. Surveil-
lance blood cultures resulted negative at the end of anti-
biotic therapy. Anidulafungin therapy was protracted for
2months until negativization of serum beta-D-glucan.
Antimicrobial therapy management was discussed dur-
ing multidisciplinary meetings which involved nephrolo-
gists, infectious diseases specialists and surgeons. The
patient was strictly evaluated by the infectious disease
team with almost daily evaluations.
After 6 months of follow up the patient is in good gen-
eral conditions in extracorporeal hemodialysis; no other
vascular or infective complications occurred and color-
Doppler examination of the iliac vessels resulted normal.
Similar complications in the recipient of the other kid-
ney were excluded by CT-scan and ultrasound (US),
both negative for aneurysm or bleeding. The recipient of
the other kidney did not develop positive blood cultures
for Candida or P. aeruginosa; instead he developed posi-
tive blood cultures for E. coli and underwent antibiotic
treatment with Ceftriaxone.
Discussion and conclusion
Infections are common in kidney allograft recipients and
according the time of onset show different epidemiology.
In the first post-transplant period the severity of infec-
tions is related to both pathogen characteristics and the
intense immunosuppression [1].
During the last years the necessity to expand the
donor pool led to an increase of DCD utilization. This
kind of transplants assure good outcomes in terms of
graft function, except for a higher incidence of DGF and
infective complications and lower patient survival [7, 8].
However, there is only partial evidence that post-transplant
infection risk could be higher in DCD kidney transplants
compared to the DBD ones [4, 8, 9]. In order to reduce
complications related to longer warm and cold ischemia
times, the DCD donor management is very complex and
must be fast, due to the need of maintaining circulation
during organ retrieval and of pre-implantation machine
perfusion of organs [6, 8]. All of these steps represent pos-
sible contamination sources, that add to the already known
potential infectious risk of the donor [10].
Infectious arteritis is a rare condition, presenting in
patients immunocompromised or subject to invasive
procedures. In the context of renal transplantation there
are reports of graft artery aneurisms that presented at
different post-transplant times, with variable clinical
presentation, i.e. hypertension or declining renal func-
tion, and with the US evidence of pseudoaneurysm. In
most cases the pathogen was a fungus already isolated
from blood cultures of the recipient [11–19]. A study on
a large number of donors, examining closely the possible
source of infection, has demonstrated that patients who
received a kidney with positive Candida spp. isolates
from the donor, eventually developed candidiasis [19].
However, there are reported cases in which a known
Candida spp. contamination in the donor did not exert
any disease in the recipient [15].
In our patient the source of infection was difficult to
define. In fact, we excluded contamination of the kidney
perfusate since cultures resulted negative, and from do-
nor’s blood cultures only a multi-sensitive Escherichia
coli was isolated. Besides, in our patient the presence of
an arterial pseudoaneurysm or aneurism was not de-
tected by routine ultrasounds that we perform every
other day. Moreover, the surveillance blood cultures we
performed because of the donor Escherichia coli blood
positivity resulted persistently negative.
Overall our patient presented with an unusual and
insidious clinical picture as sometimes candidiasis does
[2, 20]. In fact, we dealt with a severe disease that ap-
peared suddenly without any of the typical signs of
infection from Candida spp. or gram-negative E.coli
ESBL or with local evidence of disease, i.e. US evidence
of aneurism or collection.
Considering the potentially fatal outcome of arterial
rupture due to infective arteritis with an atypical
presentation, as in our case, this diagnostic hypothesis
- in the setting of a donor and a graft that underwent
invasive procedures - should be always considered. Of
course, any attempt to identify a possible transmission
from the donor must be achieved, even considering
the potential low sensitivity and false negative results
of cultures for fungi.
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As a standard of care cultures of all organ preservation
solutions and of donor’s blood and urine should be per-
formed. Moreover, surveillance cultures of recipient’s
blood, urine and drainage fluid of kidney surgical site
should be carried out in presence of early symptoms of
an active infection, in order to begin a targeted anti-
microbial therapy as soon as possible.
Therefore anti-fungal prophylaxis should be taken in
account in patients at high risk of invasive fungal infec-
tions, although it is difficult to determine which patients
belong to this category [19].
Antifungal prophylaxis may be proposed to patients
with risk factors, i.e., when preservation solution is posi-
tive for hyphae, when donor is colonized or when the re-
cipient undergoes induction with thymoglobulin.
Prophylaxis may be started just before transplantation
on day 0 and antifungal prophylaxis using an echinocan-
din could be considered, although the data to support the
use of a specific antifungal drug or the duration of the
prophylaxis are currently scarce. Moreover, a prophylaxis
of fungal infections, which have a low incidence rate,
could expose the patient to resistance phenomena and po-
tentially worsen the clinical picture [2, 10]. Certainly the
best strategy is to stratify patients according to their risk.
On the other hand, the case of our patient shed light
on the potential risk of fungal or E.coli ESBL infections
using DCD managed with ECMO and ex-vivo perfusion
[10, 21, 22]. In this setting an antifungal prophylaxis
may be suggested, even if cultures from donor’s blood
and from preservation fluids result negative.
Of course, a periodic US surveillance of graft anasto-
moses might be a valid strategy to prevent vascular compli-
cations, at least in cases where candidemia or sepsis
hesitate in the formation of an arterial pseudoaneurysm or
aneurism. In such cases, a strategy with either surgery or
endovascular approach using covered stent can be planned
and used as an effective method to prevent or stop bleed-
ing, subsequently preserving the graft and patient survival.
In our case, even a prompt CT scan had not led to a de-
finitive immediate diagnosis. In fact, only the revision of the
first CT showed a minimal leakage in the arterial phase,
that was probably due to a progressive rupture of the renal
artery (Fig. 1c). At that time point a potential treatment
with covered arterial stent or surgery with the replacement
of the anastomosis could be considered [13, 14, 23].
The timing of diagnosis and surgical treatment is cru-
cial to save the graft and the patient, but the surgical re-
pair of the artery even with an autologous graft remains
difficult to apply in an emergency setting.
Arteritis is a rare post-kidney transplant complication, but
once occurred, is associated with high mortality and graft
loss rate. The serious sequelae of these infections, mostly re-
lated to candidiasis, require an active post-transplant surveil-
lance program in order to undertake a prompt targeted
anti-infective prophylaxis or therapy. It is essential to repeat-
edly evaluate the patient with infectious disease specialists
and to discuss the onset of each antimicrobial therapy after
multidisciplinary meetings and discussions. In patients at
high risk of infections, such as DCD recipients, an antifungal
prophylaxis may be advocated. On the other hand, we need
to consider that the application of ECMO and ex-situ organ
perfusion in the setting of DCDs in Italy (which by law re-
quire 20min of no touch period to declare circulatory
death) is a novel clinical field with a low number of cases
performed; for such reasons we do not know yet the actual
rate of infection related to these procedure.
To date there is no evidence in literature, we can say
that prophylaxis can be risky for everyone.
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